INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 161 filers reported holding INTERSECT ENT INC in Q2 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $607,173 | +59.1% | 21,677 | +55.2% | 0.00% | +33.3% |
| Q4 2021 | $381,548 | +0.4% | 13,971 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $380,011 | +59.2% | 13,971 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $238,764 | -18.2% | 13,971 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $291,714 | -8.8% | 13,971 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $319,936 | +40.4% | 13,971 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $227,867 | +20.5% | 13,971 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $189,167 | +14.3% | 13,971 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $165,556 | -52.4% | 13,971 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $347,878 | +46.4% | 13,971 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $237,647 | -25.3% | 13,971 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $317,980 | -29.2% | 13,971 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $449,168 | +14.1% | 13,971 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $393,703 | -2.0% | 13,971 | 0.0% | 0.01% | +25.0% |
| Q3 2018 | $401,666 | -23.2% | 13,971 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $523,000 | +16.5% | 13,971 | +22.2% | 0.01% | +20.0% |
| Q1 2018 | $449,000 | +21.4% | 11,434 | 0.0% | 0.01% | +25.0% |
| Q4 2017 | $370,000 | – | 11,434 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|